224 related articles for article (PubMed ID: 31229264)
21. Investigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma.
Martin-Liberal J; Pérez E; García Del Muro X
Expert Opin Investig Drugs; 2019 Jan; 28(1):39-50. PubMed ID: 30513001
[TBL] [Abstract][Full Text] [Related]
22. Is There Value in Molecular Profiling of Soft-Tissue Sarcoma?
Italiano A
Curr Treat Options Oncol; 2018 Dec; 19(12):78. PubMed ID: 30523434
[TBL] [Abstract][Full Text] [Related]
23. [Molecular biology of sarcoma and therapeutic choices].
Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
[TBL] [Abstract][Full Text] [Related]
24. Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities.
Jeong S; Afroz S; Kang D; Noh J; Suh J; Kim JH; You HJ; Kang HG; Kim YJ; Kim JH
Mol Cells; 2023 Oct; 46(10):579-588. PubMed ID: 37853684
[TBL] [Abstract][Full Text] [Related]
25. Targeted Therapies in the Treatment of Sarcomas.
Hoffner B; Elias AD; Villalobos VM
Target Oncol; 2018 Oct; 13(5):557-565. PubMed ID: 30143942
[TBL] [Abstract][Full Text] [Related]
26. Management of localized extremity and retroperitoneal soft tissue sarcoma.
Abaricia S; Van Tine BA
Curr Probl Cancer; 2019 Aug; 43(4):273-282. PubMed ID: 31221500
[TBL] [Abstract][Full Text] [Related]
27. Sarcomas of soft tissue and bone.
Mazanet R; Antman KH
Cancer; 1991 Aug; 68(3):463-73. PubMed ID: 2065265
[TBL] [Abstract][Full Text] [Related]
28. Options for treating different soft tissue sarcoma subtypes.
Ray-Coquard I; Serre D; Reichardt P; Martín-Broto J; Bauer S
Future Oncol; 2018 May; 14(10s):25-49. PubMed ID: 29768052
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapeutic approaches to sarcoma.
Burgess M; Tawbi H
Curr Treat Options Oncol; 2015 Jun; 16(6):26. PubMed ID: 25975445
[TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapeutic strategies for epithelioid sarcoma: are we any closer to a non-surgical cure?
Meissner M; Napolitano A; Thway K; Huang P; Jones RL
Expert Opin Pharmacother; 2023; 24(12):1395-1401. PubMed ID: 37326105
[TBL] [Abstract][Full Text] [Related]
31. Metastatic soft tissue sarcoma: current treatment landscape and future perspectives.
Skafida E; Kokkali S; Nikolaou M; Digklia A
Expert Rev Anticancer Ther; 2017 Jun; 17(6):537-543. PubMed ID: 28425820
[TBL] [Abstract][Full Text] [Related]
32. Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas.
Kerrison WGJ; Lee ATJ; Thway K; Jones RL; Huang PH
Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327375
[TBL] [Abstract][Full Text] [Related]
33. [Roles of Histopathological Diagnosis in Multidisciplinary Therapy for Soft-Tissue Sarcoma].
Maekawa A; Oda Y
Gan To Kagaku Ryoho; 2016 Jan; 43(1):24-6. PubMed ID: 26809523
[TBL] [Abstract][Full Text] [Related]
34. Soft tissue sarcoma in children: prognosis and management.
Koscielniak E; Morgan M; Treuner J
Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy for Soft Tissue Sarcoma: Tomorrow Is Only a Day Away.
Lee A; Huang P; DeMatteo RP; Pollack SM
Am Soc Clin Oncol Educ Book; 2016; 35():281-90. PubMed ID: 27249707
[TBL] [Abstract][Full Text] [Related]
36. Developments in Systemic Therapy for Soft Tissue and Bone Sarcomas.
George S
J Natl Compr Canc Netw; 2019 May; 17(5.5):625-628. PubMed ID: 31117040
[TBL] [Abstract][Full Text] [Related]
37. Targeted therapies for sarcomas: new roles for the pathologist.
Al-Zaid T; Somaiah N; Lazar AJ
Histopathology; 2014 Jan; 64(1):119-33. PubMed ID: 24117526
[TBL] [Abstract][Full Text] [Related]
38. New molecular targets and biological therapies in sarcomas.
Scappaticci FA; Marina N
Cancer Treat Rev; 2001 Dec; 27(6):317-26. PubMed ID: 11908925
[TBL] [Abstract][Full Text] [Related]
39. New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype.
Lim J; Poulin NM; Nielsen TO
Clin Cancer Res; 2015 Nov; 21(21):4753-9. PubMed ID: 26330427
[TBL] [Abstract][Full Text] [Related]
40. [Molecular Target Therapy for Soft Tissue Sarcoma].
Takahashi S
Gan To Kagaku Ryoho; 2017 Jun; 44(6):457-462. PubMed ID: 28698433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
